The β-blocker heart attack trial: studies of platelets and factor VIII
- 1 October 1982
- journal article
- research article
- Published by Elsevier BV in Thrombosis Research
- Vol. 28 (2), 261-267
- https://doi.org/10.1016/0049-3848(82)90267-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- ANTI-PLATELET ACTIVITY OF BETA-ADRENERGIC ANTAGONISTS: INHIBITION OF THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION IN PATIENTS RECEIVING LONG-TERM PROPRANOLOL TREATMENTThe Lancet, 1981
- Sequential Changes in Factor VIII and Platelets Preceding Deep Vein Thrombosis in Patients with Spinal Cord InjuryBritish Journal of Haematology, 1980
- PROTECTIVE EFFECT OF PROPRANOLOL IN THREATENED MYOCARDIAL INFARCTIONThe Lancet, 1978
- Reversal of Abnormal Platelet Aggregability and Change in Exercise Tolerance in Patients with Angina Pectoris Following Oral PropranololCirculation, 1974
- A NEW METHOD FOR THE QUANTITATIVE DETECTION OF PLATELET AGGREGATES IN PATIENTS WITH ARTERIAL INSUFFICIENCYThe Lancet, 1974
- Quantitative Assay of a Plasma Factor Deficient in von Willebrand's Disease that is Necessary for Platelet Aggregation. RELATIONSHIP TO FACTOR VIII PROCOAGULANT ACTIVITY AND ANTIGEN CONTENTJCI Insight, 1973
- Electroimmuno AssayScandinavian Journal of Clinical and Laboratory Investigation, 1972
- Factor VIII (Anti-hemophilic factor)Journal of Chronic Diseases, 1970
- ALTERATIONS OF FIBRINOLYSIS AND BLOOD COAGULATION INDUCED BY EXERCISE, AND THE ROLE OF BETA-ADRENERGIC-RECEPTOR STIMULATIONThe Lancet, 1968
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962